JP4896501B2 - 血中遊離脂肪酸低下作用を有する医薬組成物 - Google Patents

血中遊離脂肪酸低下作用を有する医薬組成物 Download PDF

Info

Publication number
JP4896501B2
JP4896501B2 JP2005335154A JP2005335154A JP4896501B2 JP 4896501 B2 JP4896501 B2 JP 4896501B2 JP 2005335154 A JP2005335154 A JP 2005335154A JP 2005335154 A JP2005335154 A JP 2005335154A JP 4896501 B2 JP4896501 B2 JP 4896501B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
ubidecarenone
blood
hmg
coa reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005335154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006176498A5 (enExample
JP2006176498A (ja
Inventor
保博 鳥住
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Daiichi Sankyo Healthcare Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Daiichi Sankyo Healthcare Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Daiichi Sankyo Healthcare Co Ltd filed Critical Daiichi Sankyo Co Ltd
Priority to JP2005335154A priority Critical patent/JP4896501B2/ja
Publication of JP2006176498A publication Critical patent/JP2006176498A/ja
Publication of JP2006176498A5 publication Critical patent/JP2006176498A5/ja
Application granted granted Critical
Publication of JP4896501B2 publication Critical patent/JP4896501B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2005335154A 2004-11-26 2005-11-21 血中遊離脂肪酸低下作用を有する医薬組成物 Expired - Fee Related JP4896501B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005335154A JP4896501B2 (ja) 2004-11-26 2005-11-21 血中遊離脂肪酸低下作用を有する医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004341493 2004-11-26
JP2004341493 2004-11-26
JP2005335154A JP4896501B2 (ja) 2004-11-26 2005-11-21 血中遊離脂肪酸低下作用を有する医薬組成物

Publications (3)

Publication Number Publication Date
JP2006176498A JP2006176498A (ja) 2006-07-06
JP2006176498A5 JP2006176498A5 (enExample) 2009-01-29
JP4896501B2 true JP4896501B2 (ja) 2012-03-14

Family

ID=36730936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005335154A Expired - Fee Related JP4896501B2 (ja) 2004-11-26 2005-11-21 血中遊離脂肪酸低下作用を有する医薬組成物

Country Status (1)

Country Link
JP (1) JP4896501B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012096998A (ja) * 2009-02-27 2012-05-24 Kowa Co 安定なカプセル製剤及びその製造方法
TWI636783B (zh) * 2012-04-18 2018-10-01 友霖生技醫藥股份有限公司 含匹伐他汀（ｐｉｔａｖａｓｔａｔｉｎ）穩定配方的醫藥組合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007983C (en) * 1989-01-18 1996-12-10 Michael S. Brown Coenzyme q10 with hmg-coa reductase inhibitors
US5316765A (en) * 1989-09-07 1994-05-31 Karl Folkers Foundation For Biomedical And Clinical Research Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies
AUPR177300A0 (en) * 2000-11-29 2000-12-21 Centre For Molecular Biology And Medicine Therapeutic methods
JP2003081873A (ja) * 2001-06-28 2003-03-19 Takeda Chem Ind Ltd 臓器機能障害および臓器不全の予防治療剤
JP2005525401A (ja) * 2002-04-23 2005-08-25 ニュートリション ２１、インコーポレイテッド 薬剤誘発インスリン抵抗性を阻害するためのクロム組成物およびその使用方法

Also Published As

Publication number Publication date
JP2006176498A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
JP7442095B2 (ja) ベータ－ヒドロキシブチレート及びブタンジオールのｓ－エナンチオマー並びにその使用方法
CN101972260B (zh) 一种瑞舒伐他汀钙口服药物组合物
JP2010077162A (ja) 血中ホモシステイン低下のための医薬組成物
TWI284529B (en) A composition for lowering triglyceride
CN107126423B (zh) 匹伐他汀钙片剂药物组合物及其干式或湿式制备方法
US20040014712A1 (en) Blood lipid ameliorant composition
JP5226980B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤、トコフェロール類及びＣｏＱ１０を含有する医薬組成物
JP4896501B2 (ja) 血中遊離脂肪酸低下作用を有する医薬組成物
JP2008189684A (ja) 血中脂質改善剤組成物
CN101411703A (zh) 一种治疗心血管疾病的药物组合物
CA2534660A1 (en) Single unit pharmaceutical composition comprising a mixture of a fibrate and an homocysteine reducing agent
JP4949661B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物
US7037934B2 (en) Blood lipid ameliorant composition
KR102289381B1 (ko) 당뇨치료제 및 고지혈증 치료제를 포함하는 약학적 조성물
US20080070938A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocysteine
JP2007513991A (ja) メタボリック症候群の処置のためのスタチンの使用
JP2022183126A (ja) オリーブオイル脂肪酸からのアシルエタノールアミドの組成物
WO2001085155A1 (en) Method and compositions for inhibiting arteriosclerosis
WO2006057209A1 (ja) 血中遊離脂肪酸低下作用を有する医薬組成物
JP4607436B2 (ja) ＨＭＧ−ＣｏＡリダクターゼ阻害剤を含有する医薬組成物
EP2604258A1 (en) Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity
JP4212271B2 (ja) 血中脂質改善剤組成物
JPH09227371A (ja) 粥状動脈硬化抑制剤
JP2005225871A (ja) 血中トリグリセライド又はホモシステインを低下させる医薬組成物
WO2006033287A1 (ja) ＨＭＧ－ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物。

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060524

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081106

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20081106

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20081106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111111

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111214

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111221

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150106

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees